SCOPUS 정보 검색 플랫폼

Volumn 6, Issue 12, 2000, Pages 4885-4892

Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase

(5) Sirotnak, F M a Zakowski, M F a Miller, V A a Scher, H I a Kris, M G a

a MEMORIAL SLOAN KETTERING CANCER CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYTOTOXIC AGENT; DOXORUBICIN; EDATREXATE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GEFITINIB; GEMCITABINE; PLATINUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER REGRESSION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG TOLERANCE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG CARCINOMA; MAXIMUM TOLERATED DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR XENOGRAFT; VULVA CARCINOMA;

AMINOPTERIN; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY WEIGHT; CARBOPLATIN; CELL DIVISION; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PACLITAXEL; PROSTATIC NEOPLASMS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAXOIDS; TIME FACTORS; TUMOR CELLS, CULTURED; VINBLASTINE; VULVAR NEOPLASMS;

EID: 0034489914 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (787)

References (22)

1
- 0022481299
- Expression in rat fibroblasts of human transforming growth factor-α cDNA results in transformation
- (1986) Cell , vol.46 , pp. 301-309
- Rosenthal, A.¹ Lindquist, P.B.² Bringman, T.S.³ Goeddel, D.V.⁴ Derynck, R.⁵

2
- 0024355092
- Autocrine interaction between TGF-α and the EGF-receptor: Quantitative requirements for induction of the malignant phenotype
- (1989) Oncogene , vol.4 , pp. 831-838
- DiMarco, E.¹ Pierce, J.H.² Fleming, T.P.³ Kraus, M.H.⁴ Molloy, C.J.⁵ Aaronson, S.A.⁶ Di Fiore, P.P.⁷

3
- 0024337144
- Studies of the Her-2/neu proto-oncogene in human breast and ovarian cancer
- (1989) Science (Washington DC) , vol.244 , pp. 707-712
- Slamon, D.J.¹ Godolphin, W.² Jones, L.³ Holt, J.⁴ Wong, S.⁵ Keith, D.⁶ Levin, W.⁷ Stuart, S.⁸ Udone, J.⁹ Velrich, A.¹⁰ Press, M.F.¹¹

4
- 0001261042
- Studies of the Her2/neu oncogene in human breast cancer
- (1989) Cancer Cells (Cold Spring Harbor) , vol.7 , pp. 371-379
- Slamon, D.¹ Press, M.² Godolphin, W.³ Ramos, L.⁴ Harlan, P.⁵ Shek, L.⁶ Stuart, S.⁷ Ulrich, H.⁸

5
- 0020933452
- Biological effects in vitro of monoclonal antibodies to human EGF receptors
- (1983) Mol. Biol. Med. , vol.1 , pp. 511-529
- Sato, J.D.¹ Kawamoto, T.² Le, A.D.³ Mendelsohn, J.⁴ Polikoff, J.⁵ Sato, G.H.⁶

6
- 0026174552
- Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth
- (1991) Growth Regul. , vol.1 , pp. 72-82
- Sarup, J.C.¹ Johnson, R.M.² King, K.L.³ Fendly, B.M.⁴ Lipari, M.T.⁵ Napier, M.A.⁶ Ullrich, A.⁷ Shepard, H.M.⁸

7
- 0021363327
- Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies
- (1984) Cancer Res. , vol.44 , pp. 1002-1007
- Masui, H.¹ Kawamoto, T.² Sato, J.D.³ Wolf, B.⁴ Sato, G.⁵ Mendelsohn, J.⁶

8
- 0000025117
- Anti-p185HER2 monoclonal antibodies: Biological properties and potential for immunotherapy
- R. B. Dickson and M. E. Lippman (eds.), Genes, Oncogenes and Hormones. Advances in Cellular and Molecular Biology of Breast Cancer. Boston: Kluiwer Academic Publishers
- (1991) , pp. 194-211
- Park, J.W.¹ Stagg, R.² Lewis, G.D.³ Carter, P.⁴ Maneval, D.⁵ Slamon, D.J.⁶ Jaffe, H.⁷ Shepard, H.M.⁸

9
- 0029991439
- Her2 monoclonal antibody in patients with Her2/neu-overexpressing metastatic breast cancer
- (1996) J. Clin. Oncol. , vol.14 , pp. 737-744
- Baselga, J.¹ Tripathy, D.² Mendelsohn, J.³ Baughman, S.⁴ Benz, C.C.⁵ Dantis, L.⁶ Sklarin, N.T.⁷ Seidman, A.D.⁸ Hudis, C.A.⁹ Moore, J.¹⁰ Rosen, P.P.¹¹ Twaddell, T.¹² Henderson, I.C.¹³ Norton, L.¹⁴

10
- 0027428571
- Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts
- (1993) Cancer Res. , vol.53 , pp. 4637-4642
- Fan, Z.¹ Baselga, J.² Masui, H.³ Mendelsohn, J.⁴

11
- 0027290650
- Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies
- (1993) J. Natl. Cancer Inst. , vol.85 , pp. 1327-1333
- Baselga, J.¹ Norton, L.² Masui, H.³ Pandiella, A.⁴ Coplan, K.⁵ Miller, W.H.⁶ Mendelsohn, J.⁷

12
- 0028200221
- Antibody to HER2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells
- (1994) Oncogene , vol.9 , pp. 1829-1838
- Pietras, R.J.¹ Fendly, B.M.² Chazin, V.R.³ Pegram, M.D.⁴ Howell, S.B.⁵ Slamon, D.J.⁶

13
- 0025986825
- A monoclonal antibody against c-erb-B-2 protein enhances the cytotoxicity of diamminedichloroplatinum against human breast and ovarian tumor cell lines
- (1991) Cancer Res. , vol.51 , pp. 4575-4580
- Hancock, M.C.¹ Langton, B.C.² Chan, T.³ Toy, P.⁴ Monahan, J.J.⁵ Mischak, R.P.⁶ Shawver, L.K.⁷

14
- 0033559619
- Monoclonal antibody to HER-2/neu receptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene
- (1999) Cancer Res. , vol.59 , pp. 1347-1355
- Pietras, R.J.¹ Poen, J.C.² Gallardo, D.³ Wongvipat, P.N.⁴ Lee, J.H.⁵ Slamon, D.J.⁶

15
- 0031903646
- Her2/neu monoclonal antibody plus cis platinum in patients with Her2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment
- (1998) J. Clin. Oncol. , vol.16 , pp. 2659-2671
- Pegram, M.D.¹ Lipton, A.² Hayes, D.F.³ Weber, B.L.⁴ Baselga, J.M.⁵ Tripathy, D.⁶ Baly, D.⁷ Baughman, S.A.⁸ Twaddell, T.⁹ Glaspy, J.A.¹⁰ Slamon, D.J.¹¹

16
- 0031887743
- Protein kinase inhibitors: The tyrosine-specific protein kinases
- (1998) Pharmacol. Ther. , vol.77 , pp. 81-114
- Lawrence, D.S.¹ Niu, J.²

17
- 0000285504
- ZD1839, an epidermal growth factor tyrosine kinase inhibitor selected for clinical development
- (1997) Proc. Am. Assoc. Cancer Res. , vol.38 , pp. 633
- Woodburn, J.R.¹ Barker, A.J.² Gibson, K.H.³ Ashton, S.E.⁴ Wakeling, A.E.⁵ Carry, B.J.⁶ Scarlett, L.⁷ Henthorn, L.R.⁸

18
- 0004252445
- Englewood Cliffs, NJ: Prentice Hall
- (1984) Biostatistical Analysis, 2nd ed. , pp. 145-146
- Zar, J.H.¹

19
- 0029049891
- Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor α in the progression of prostatic neoplasms
- (1995) Clin. Cancer Res. , vol.1 , pp. 545-550
- Scher, H.I.¹ Sarkis, A.² Reuter, V.³ Cohen, D.⁴ Netto, G.⁵ Petrylak, D.⁶ Lianes, P.⁷ Fuks, Z.⁸ Mendelsohn, J.⁹ Cordon-Cordo, C.¹⁰

20
- 0030740799
- Changes of biological features in breast cancer cells determined by primary chemotherapy
- (1997) Breast Cancer Res. Treat. , vol.44 , pp. 185-192
- Frassoldati, A.¹ Adami, F.² Banzi, C.³ Criscuolo, M.⁴ Piccinini, L.⁵ Silingardi, V.⁶

21
- 0031417680
- Altered gene expression in drug-resistant human breast cancer cells
- (1997) Clin. Cancer Res. , vol.3 , pp. 2405-2414
- Wosikowski, K.¹ Schuurhuis, C.² Kops, G.J.³ Saceda, M.⁴ Bates, S.E.⁵

22
- 0000046996
- ZD1839 ('Iressa') a selective growth factor receptor kinase inhibitor (EGFR-TKI): Inhibition of c-fos mRNA, an intermediate marker of EGFR activation, correlates with tumor growth inhibition
- (2000) Proc. Am. Assoc. Cancer Res. , vol.41 , pp. 402
- Woodburn, J.R.¹ Kendrew, J.² Fennell, M.³ Wakeling, A.E.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.